Figure 2.
Uptake of platinum by cancer and noncancer cells. (A) Total platinum uptake (ng) in samples of one million treated cells accurately quantified by ICP MS. (B) Platinum uptake ratios (intracellular: extracellular platinum) in cancer and noncancer cells. In both cases, a statistically significant increase in cellular uptake of platinum with PEGylated liposomal nedaplatin (LND) compared to ND was observed specifically in the cancer cells lines (p-value < 0.05). Multiple pair-wise t-tests showed the cell lines where a significant difference in platinum uptake between LND and ND was observed. These points are indicated by asterisks * (p < 0.05) in the charts above.
